dCas9-TET1CD was used to demethylate the EphA7 gene: the protein correlates with life expectancy in cervical cancer, indicating the potential of dCas9-TET1CD as a therapeutic strategy for cervical cancer [151]. The gene discussed is EPHA7; the disease is cervical carcinoma.